Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors

PURPOSE: Arthralgia occurs in up to 50% of breast cancer survivors treated with aromatase inhibitors (AIs) and is the most common reason for poor AI adherence. We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgia, a yearlong randomized trial of the impact of exercise...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Irwin, Melinda L., Cartmel, Brenda, Gross, Cary P., Ercolano, Elizabeth, Li, Fangyong, Yao, Xiaopan, Fiellin, Martha, Capozza, Scott, Rothbard, Marianna, Zhou, Yang, Harrigan, Maura, Sanft, Tara, Schmitz, Kathryn, Neogi, Tuhina, Hershman, Dawn, Ligibel, Jennifer
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2015
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372849/
https://ncbi.nlm.nih.gov/pubmed/25452437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.1547
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы